804. Impact of Azithromycin Prophylaxis in Lung Transplant Recipients on the Risk of Nontuberculous Mycobacterial Infections

BACKGROUND: Azithromycin has been shown to improve FEV1 in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS). The impact of azithromycin use on the incidence of infections due to Mycobacterium avium complex (MAC) and M. abscessus in LTR is currently unknown. METHODS: We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Workman, Adrienne, Kaza, Vaidehi, Bennett, Scott, Chong, Pearlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254516/
http://dx.doi.org/10.1093/ofid/ofy210.811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254516/
http://dx.doi.org/10.1093/ofid/ofy210.811

Ejemplares similares